MDCell offers its cutting edge technologies as tailored service to enable customers efficient gene engineering of cells, high-level protein expression as well as pre-clinical assays for gene and cell therapy development with specific expertise around primary human T cells.
- Gene-insertion in primary cells and cell lines (SB, retrovirus)
- Cloning of gene of interest in target plasmids and plasmid preparations
- TCR gene sequence optimization for high level expression
- Functional assays of TCR and CAR-engineering T cells
MDCell provides a platform to perform research collaboration projects to develop:
- Cell and gene therapy products
- Cell processing and gene delivery technologies and devices
- TCR- and CAR-engineered T cells for cancer immunotherapy / immunooncology.
Send us an informal quote of your needs!
Phone: +49 30 9406 3847